AU667815B2 - Therapeutic compositions for osteoinduction - Google Patents

Therapeutic compositions for osteoinduction Download PDF

Info

Publication number
AU667815B2
AU667815B2 AU21454/92A AU2145492A AU667815B2 AU 667815 B2 AU667815 B2 AU 667815B2 AU 21454/92 A AU21454/92 A AU 21454/92A AU 2145492 A AU2145492 A AU 2145492A AU 667815 B2 AU667815 B2 AU 667815B2
Authority
AU
Australia
Prior art keywords
bmp
vitamin
compound
safe
dihydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU21454/92A
Other languages
English (en)
Other versions
AU2145492A (en
Inventor
Roger Lee Stone
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Publication of AU2145492A publication Critical patent/AU2145492A/en
Application granted granted Critical
Publication of AU667815B2 publication Critical patent/AU667815B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1875—Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU21454/92A 1991-06-05 1992-05-26 Therapeutic compositions for osteoinduction Ceased AU667815B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US70962191A 1991-06-05 1991-06-05
US709621 1991-06-05
US85611092A 1992-03-27 1992-03-27
US856110 1992-03-27
PCT/US1992/004356 WO1992021365A1 (en) 1991-06-05 1992-05-26 Therapeutic compositions for osteoinduction

Publications (2)

Publication Number Publication Date
AU2145492A AU2145492A (en) 1993-01-08
AU667815B2 true AU667815B2 (en) 1996-04-18

Family

ID=27108286

Family Applications (1)

Application Number Title Priority Date Filing Date
AU21454/92A Ceased AU667815B2 (en) 1991-06-05 1992-05-26 Therapeutic compositions for osteoinduction

Country Status (13)

Country Link
EP (1) EP0587751A1 (no)
JP (1) JPH06508140A (no)
AU (1) AU667815B2 (no)
BR (1) BR9206110A (no)
CA (1) CA2110410C (no)
CZ (1) CZ282231B6 (no)
IE (1) IE921812A1 (no)
NO (1) NO934381L (no)
NZ (1) NZ243018A (no)
PT (1) PT100567A (no)
RU (1) RU2107512C1 (no)
SK (1) SK136693A3 (no)
WO (1) WO1992021365A1 (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5674844A (en) * 1991-03-11 1997-10-07 Creative Biomolecules, Inc. Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases
US7056882B2 (en) 1991-03-11 2006-06-06 Curis, Inc. Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases
EP0601135B1 (en) * 1991-08-30 2005-11-02 Curis, Inc. Osteogenic proteins in the treatment of metabolic bone diseases
US6071695A (en) * 1992-02-21 2000-06-06 Creative Biomolecules, Inc. Methods and products for identification of modulators of osteogenic protein-1 gene expression
CN1104257C (zh) * 1993-03-29 2003-04-02 津莫吉尼蒂克斯公司 含pdgf和维生素d的刺激成骨细胞生长的组合物
CA2191583C (en) * 1994-06-07 2007-03-27 Engin Ozkaynak Methods and compositions for modulating morphogenic protein expression
US7026292B1 (en) 1995-12-12 2006-04-11 Stryker Corporation Compositions and therapeutic methods using morphogenic proteins and stimulatory factors
US6048964A (en) * 1995-12-12 2000-04-11 Stryker Corporation Compositions and therapeutic methods using morphogenic proteins and stimulatory factors
US6492508B1 (en) 1996-06-03 2002-12-10 United States Surgical Corp. A Division Of Tyco Healthcare Group Nucleic acids encoding extracellular matrix proteins
EP2332564A1 (en) * 1997-02-07 2011-06-15 Stryker Corporation Matrix-free osteogenic devices, implants and methods thereof
JP4255382B2 (ja) * 2001-10-31 2009-04-15 アルコン，インコーポレイテッド 骨形成タンパク質（ｂｍｐ）、ｂｍｐレセプターおよびｂｍｐ結合タンパク質ならびに緑内障の診断および処置におけるそれらの使用
CN104257667B (zh) * 2007-04-25 2019-06-04 欧普科Ip 控股Ii 有限公司 治疗维生素d不足和缺乏、继发性甲状旁腺功能亢进症和维生素d-响应疾病的方法和组合物
US20100204123A1 (en) * 2009-02-12 2010-08-12 Mary Elizabeth Pecquet Goad Peripheral Administration of Proteins Including TGF-beta Superfamily Members for Treatment of Systemic Disorders and Disease
CA2752160A1 (en) * 2009-02-12 2010-08-19 Stryker Corporation Compositions and methods for minimally-invasive systemic delivery of proteins including tgf-.beta. superfamily members
RU2595804C1 (ru) * 2015-04-23 2016-08-27 Федеральное государственное бюджетное образовательное учреждение высшего образования "Саратовский государственный технический университет имени Гагарина Ю.А." (СГТУ имени Гагарина Ю.А.) Состав для получения стоматологической лечебно-профилактической пленки

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4833125A (en) * 1986-12-05 1989-05-23 The General Hospital Corporation Method of increasing bone mass

Also Published As

Publication number Publication date
CA2110410C (en) 1997-04-15
EP0587751A1 (en) 1994-03-23
WO1992021365A1 (en) 1992-12-10
PT100567A (pt) 1994-01-31
NZ243018A (en) 1995-12-21
AU2145492A (en) 1993-01-08
IE921812A1 (en) 1992-12-16
CZ262493A3 (en) 1994-07-13
BR9206110A (pt) 1995-07-11
SK136693A3 (en) 1994-10-05
CA2110410A1 (en) 1992-12-10
NO934381D0 (no) 1993-12-02
NO934381L (no) 1994-01-31
JPH06508140A (ja) 1994-09-14
RU2107512C1 (ru) 1998-03-27
CZ282231B6 (cs) 1997-06-11

Similar Documents

Publication Publication Date Title
US5693615A (en) Therapeutic compositions for osteoinduction
AU667815B2 (en) Therapeutic compositions for osteoinduction
US5422340A (en) TGF-βformulation for inducing bone growth
EP0679097B1 (en) Tgf-beta formulation for inducing bone growth
Simion et al. Vertical ridge augmentation by means of deproteinized bovine bone block and recombinant human platelet-derived growth factor-BB: a histologic study in a dog model.
US7498021B2 (en) Dental products comprising bone growth enhancing peptide
King et al. Effects of occlusal loading on ankylosis, bone, and cementum formation during bone morphogenetic protein‐2‐stimulated periodontal regeneration in vivo
AU2005328325B2 (en) Activating extraction of demineralized bone matrix
US9089606B2 (en) Brain-derived neurotrophic factor or neurotrophin-4/5 to treat periodontal diseases and pulpal diseases
Barboza et al. Potential of recombinant human bone morphogenetic protein-2 in bone regeneration
US20080107706A1 (en) Osteogenic Oligonucleotides and Uses Thereof
Parimala Comparative evaluation of bovine porous bone mineral (Bio-Oss) bone craft with and without platelet rich plasma (PRP) in the treatment of periodontal intrabony defects: a clinical study

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired